Pre-, Peri-, and Neonatal Factors Associated with Autism Spectrum Disorder: Results of a Lebanese Case-control Study
- PMID: 36204169
- PMCID: PMC9507149
Pre-, Peri-, and Neonatal Factors Associated with Autism Spectrum Disorder: Results of a Lebanese Case-control Study
Abstract
Objective: The prevalence of autism spectrum disorder (ASD) in Lebanon is higher than what is reported by the World Health Organization (WHO), leading to the thought that the Lebanese population has some specific risk factors for ASD. Therefore, it is important to conduct more robust studies on this population. We conducted this study to identify pre-, peri-, and neonatal risk factors for ASD. Our ultimate goal was to detect and change some modifiable risk factors, thus reducing the incidence of ASD.
Design: A case-control study was conducted using a random proportional sample of Lebanese children with ASD to explore whether risk factors, such as family history, pregnancy (including all medication and substances taken during pregnancy and infection history), gestational age, delivery, birth milestones, and the neonate's condition at birth could be associated with a higher prevalence of ASD. The local ethical committee approved the study (USJ-2016-91), and all parents gave their written consent.
Results: A total of 66 children with ASD and 66 controls were included. The results of the multivariable analysis showed that a higher gestational weight gain (adjusted odds ratio [ORa]: 1.11) was significantly associated with higher odds of autism, whereas female sex (ORa: 0.13) and higher number of weeks of gestation (ORa: 0.76) were significantly associated with lower odds of autism.
Conclusion: Such results are of great relevance, since many of the identified factors herein could be avoidable or modifiable, suggesting the need for implementing timely and appropriate public health strategies for disease prevention in pregnant women that could reduce ASD.
Keywords: Autism spectrum disorder; case-control study; gestational weight gain; pregnancy; risk factors.
Copyright © 2022. Matrix Medical Communications. All rights reserved.
Conflict of interest statement
DISCLOSURES: The authors have no conflicts of interest relevant to the content of this article.
References
-
- World Health Organization. Meeting report: autism spectrum disorders and other developmental disorders: from raising awareness to building capacity: World Health Organization, Geneva, Switzerland16–18 September 2013. World Health Organization; 2013.
-
- Muhle RA, Reed HE, Stratigos KA, Veenstra-VanderWeele J. The emerging clinical neuroscience of autism spectrum disorder: a review. JAMA Psychiatry. 2018;75(5):514–523. - PubMed
-
- Jutla A, Reed H, Veenstra-VanderWeele J. The architecture of autism spectrum disorder risk: what do we know, and where do we go from here? JAMA Psychiatry. 2019;76(10):1005–1006. - PubMed
LinkOut - more resources
Full Text Sources